Revenue $392.40M, up 104.5% on a year earlier. Diluted EPS $0.83 against $0.29.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $392.40M | $308.36M | $191.93M | +104.5% |
| Operating income | $89.25M | $61.83M | $39.77M | +124.4% |
| Net income | $153.09M | $80.31M | $51.22M | +198.9% |
| Diluted EPS | $0.83 | $0.44 | $0.29 | |
| Operating cash flow | $87.68M | $74.60M | $135.37M | -35.2% |
| Capital expenditures | -$20.47M | -$7.59M | -$2.02M | |
| Free cash flow | $67.21M | $67.01M | $133.34M | -49.6% |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Sequential Revenue Growth | 27% | 20% |
| Period | Measure | Guided | Reported | Result |
|---|---|---|---|---|
| Q2 FY26 | Revenue | $355.00M to $365.00M | $392.40M | above |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Astera Labs (ALAB) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/ALAB/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
